S
Setsuko K. Chambers
Researcher at University of Arizona
Publications - 158
Citations - 7181
Setsuko K. Chambers is an academic researcher from University of Arizona. The author has contributed to research in topics: Ovarian cancer & Cancer. The author has an hindex of 45, co-authored 153 publications receiving 6016 citations. Previous affiliations of Setsuko K. Chambers include Yale University & University of Rochester.
Papers
More filters
Journal ArticleDOI
Procollagen-Derived Biomarkers in Malignant Ascites of Ovarian Cancer: Independent Prognosticators for Progression-Free Interval and Survival
Bernadette M. Cracchiolo,Hartmut M. Hanauske-Abel,Peter E. Schwartz,Joseph T. Chambers,Bart Holland,Setsuko K. Chambers +5 more
TL;DR: It is proposed that ascitic pnPIIINP is a fluid-phase indicator for angiogenic activity in ovarian cancer and thus represents a tumor virulence index.
Journal ArticleDOI
Strengthening Research in Departments of Obstetrics and Gynecology
John M. Bissonnette,Setsuko K. Chambers,Patricia Collins,Charles J. Lockwood,Carole R. Mendelson,Leslie Myatt,Mary Lake Polan,Wen Hui Shen,Sara E. Szal +8 more
TL;DR: 1. the success rate for members of departments of obstetrics and gynecology who apply to the National Institute of Child Health and Human Development is as good or better than for all applicants to that institute.
Journal ArticleDOI
Evaluation of a Hypoxia Regulated Gene Panel in Ovarian Cancer
Amanda F. Baker,Scott W. Malm,Ritu Pandey,Cindy Laughren,Haiyan Cui,Denise J. Roe,Setsuko K. Chambers +6 more
TL;DR: This study supports further evaluation by qNPA of this gene panel as an alternative or complimentary method to existing protein biomarkers to identify ovarian cancers with a hypoxic phenotype.
Journal ArticleDOI
Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence.
Christine Gruessner,Angelika C. Gruessner,Katherine Glaser,Nisreen Abushahin,Yi Zhou,Cynthia Laughren,Heather M. Wright,Samantha Pinkerton,Xiaofang Yi,Jha'nae B. Stoffer,Masoud Azodi,Wenxin Zheng,Setsuko K. Chambers +12 more
TL;DR: The data suggest that a short 6-week exposure of flutamide reversed elevated levels of CSF-1 and ErbB4 (both of which were previously found correlated with high risk status), and suggests that ovarian endosalpingiosis may be a latent precursor to pelvic serous cancers.
Journal ArticleDOI
Malignant uterine smooth muscle tumors: role of etoposide, cisplatin, and doxorubicin (EPA) chemotherapy.
Edward Resnik,Edward Resnik,Setsuko K. Chambers,Maria Luisa Carcangiu,E.I. Kohorn,Peter E. Schwartz,Joseph T. Chambers +6 more
TL;DR: There is no convincing evidence that the addition of pelvic radiation improves the outcome of patients with malignant uterine smooth muscle tumor, but adjuvant chemotherapy might be an appropriate therapeutic modality.